These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11096359)

  • 41. Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines.
    Holzhauser S; Lukoseviciute M; Papachristofi C; Vasilopoulou C; Herold N; Wickström M; Kostopoulou ON; Dalianis T
    Int J Oncol; 2021 Feb; 58(2):211-225. PubMed ID: 33491755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells.
    Shen F; Xue X; Weber G
    Anticancer Res; 1999; 19(3A):1657-62. PubMed ID: 10470097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Synergistic effect of toremifene and cisplatin on human lung cancer cell line A549].
    Zhang X; Li Q; Han Y; Liu Z
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):537-9. PubMed ID: 12667319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
    Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
    J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiproliferation and radiosensitization of caffeic acid phenethyl ester on human medulloblastoma cells.
    Lin YH; Chiu JH; Tseng WS; Wong TT; Chiou SH; Yen SH
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):525-32. PubMed ID: 16172905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polo-like Kinase Inhibitor Volasertib Exhibits Antitumor Activity and Synergy with Vincristine in Pediatric Malignancies.
    Abbou S; Lanvers-Kaminsky C; Daudigeos-Dubus E; LE Dret L; Laplace-Builhe C; Molenaar J; Vassal G; Geoerger B;
    Anticancer Res; 2016 Feb; 36(2):599-609. PubMed ID: 26851014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growth.
    Scambia G; Ranelletti FO; Benedetti Panici P; Bonanno G; De Vincenzo R; Piantelli M; Mancuso S
    Anticancer Drugs; 1990 Oct; 1(1):45-8. PubMed ID: 2131036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genistein inhibits growth of B16 melanoma cells in vivo and in vitro and promotes differentiation in vitro.
    Record IR; Broadbent JL; King RA; Dreosti IE; Head RJ; Tonkin AL
    Int J Cancer; 1997 Sep; 72(5):860-4. PubMed ID: 9311605
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Additive and supra-additive cytotoxicity of cisplatin-taxane combinations in ovarian carcinoma cell lines.
    Engblom P; Rantanen V; Kulmala J; Helenius H; Grènman S
    Br J Cancer; 1999 Jan; 79(2):286-92. PubMed ID: 9888470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic anticancer activity of Thiazolo[5,4-b]quinoline derivative D3CLP in combination with cisplatin in human cervical cancer cells.
    González-Sánchez I; Lira-Rocha A; Navarrete A; Loza-Mejía MA; Coronel-Cruz C; Mendoza-Rodríguez CA; Cerbón MA
    Anticancer Res; 2012 Dec; 32(12):5159-65. PubMed ID: 23225412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F; Duivenvoorden WC; Singh G
    Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methionine restriction reduces the chemosensitivity of central nervous system tumour cell lines.
    Najim N; Podmore ID; McGown A; Estlin EJ
    Anticancer Res; 2009 Aug; 29(8):3103-8. PubMed ID: 19661322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ICI D1694 and idoxuridine: a synergistic antitumor combination.
    Pressacco J; Hedley DW; Erlichman C
    Cancer Res; 1994 Jul; 54(14):3772-8. PubMed ID: 8033097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells.
    Liu JT; Li WC; Gao S; Wang F; Li XQ; Yu HQ; Fan LL; Wei W; Wang H; Sun GP
    Clin Lung Cancer; 2015 Sep; 16(5):e55-66. PubMed ID: 25979647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiproliferative effect of genistein and adriamycin against estrogen-dependent and -independent human breast carcinoma cell lines.
    Monti E; Sinha BK
    Anticancer Res; 1994; 14(3A):1221-6. PubMed ID: 8074476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic anti-cancer effects of epigenetic drugs on medulloblastoma cells.
    Yuan J; Llamas Luceño N; Sander B; Golas MM
    Cell Oncol (Dordr); 2017 Jun; 40(3):263-279. PubMed ID: 28429280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts.
    Shu Q; Antalffy B; Su JM; Adesina A; Ou CN; Pietsch T; Blaney SM; Lau CC; Li XN
    Clin Cancer Res; 2006 Aug; 12(15):4687-94. PubMed ID: 16899619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of FOXM1 by thiostrepton sensitizes medulloblastoma to the effects of chemotherapy.
    Lin J; Zheng Y; Chen K; Huang Z; Wu X; Zhang N
    Oncol Rep; 2013 Oct; 30(4):1739-44. PubMed ID: 23912794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potentiation of the radiation effect with genistein in cervical cancer cells.
    Yashar CM; Spanos WJ; Taylor DD; Gercel-Taylor C
    Gynecol Oncol; 2005 Oct; 99(1):199-205. PubMed ID: 16083949
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tamoxifen modulation of etoposide cytotoxicity involves inhibition of protein kinase C activity and insulin-like growth factor II expression in brain tumor cells.
    Ramachandran C; Khatib Z; Petkarou A; Fort J; Fonseca HB; Melnick SJ; Escalon E
    J Neurooncol; 2004; 67(1-2):19-28. PubMed ID: 15072444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.